Status:

UNKNOWN

Canadian Registry for the Use of Spectrum Therapeutics Cannabis Products in Subjects With Chronic Pain

Lead Sponsor:

Canopy Growth Corporation

Conditions:

Chronic Pain

Eligibility:

All Genders

25+ years

Brief Summary

Chronic pain affects at least 10% of the global population but is often poorly managed, given the variable efficacy of available pharmacological treatments and the limited accessibility of multidiscip...

Detailed Description

The present study is a prospective, observational registry designed to generate real-world data on the physician-recommended use of ST products for the management of chronic non-cancer pain in Canada....

Eligibility Criteria

Inclusion

  • Subject ≥ 25 years of age with a diagnosis of chronic non-cancer pain defined as pain lasting or recurring over a period \> 3 months (IASP-ICD-11 classification, refer to Appendix 6).
  • Subject is, in the physician's opinion, a candidate for medical cannabis treatment. Candidate status will be determined based on local regulations, common clinical practice, available guidelines and scientific literature, and the physician's expertise or experience with medical cannabis products.
  • Subject received a prescription/authorization for a product in the medical channel of Spectrum Therapeutics.
  • Subject is able to read and understand the informed consent form and complete the study questionnaires.

Exclusion

  • Subject refuses to provide informed consent or participate in any aspect of the study.
  • Subject is pregnant or lactating.
  • Subject has a history of psychosis or schizophrenia (or other significant psychiatric disorder), including among first-degree relatives.
  • Subject has a suspected or confirmed cardiovascular disease.
  • Subject is a liver transplant recipient or has severely compromised liver function.

Key Trial Info

Start Date :

January 25 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 30 2023

Estimated Enrollment :

500 Patients enrolled

Trial Details

Trial ID

NCT04763252

Start Date

January 25 2021

End Date

July 30 2023

Last Update

August 15 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Burrard Pain Doctors

Vancouver, British Columbia, Canada, V6Z 2C7

Canadian Registry for the Use of Spectrum Therapeutics Cannabis Products in Subjects With Chronic Pain | DecenTrialz